2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 – Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62)Steven P. Piccoli, Susan Kirshner, Alison Joyce et al.|Bioanalysis|2019Cited by 94
Comparison of Pre-existing Anti-AAV8 Total Antibody Screening and Confirmatory Assays with a Cell-Based Neutralizing Assay in Normal Human SerumYan‐Shan Dai, Vibha Jawa, Nanda Balasubramanian et al.|The AAPS Journal|2023Cited by 12
Bioanalytical Methods for Characterization of <scp>CAR‐T</scp> Cellular Kinetics: Comparison of <scp>PCR</scp> Assays and MatricesMadhan Masilamani, Sekhar Surapaneni, Tim Mack et al.|Clinical Pharmacology & Therapeutics|2023Cited by 12